GlassScriptPhysician profile
Michael Birns
NPI 1710204144
$2,373.78
in general payments reported to CMS, 2019-2025
23 companies · $377 in 2025
The $377 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $406 · 2020: $133 · 2021: $195 · 2022: $168 · 2023: $562 · 2024: $535 · 2025: $377.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,473.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,472.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $345.76 | 2019-2024 | Triathlon, Omnicurve, Optablate |
| Abbvie INC. | $291.15 | 2024-2025 | |
| Eclipse Technology Solutions INC. | $232.06 | 2022-2025 | |
| Pacira Therapeutics, INC. | $229.99 | 2019-2021 | |
| Heraeus Medical, LLC. | $191.46 | 2019-2025 | Palacos |
| Depuy Synthes Sales INC. | $156.49 | 2019-2025 | Orthovisc, Monovisc |
| Zimmer Biomet Holdings, INC. | $143.63 | 2023-2025 | Gel-One Cross-Linked Hyaluronate, Tapestry |
| Amgen INC. | $128.71 | 2019-2025 | Evenity |
| Ortho Development Corporation | $112.62 | 2021 | |
| Smith+Nephew, INC. | $105.95 | 2019-2024 | Or3o Dual Mobility |
| Fidia Pharma USA INC. | $74.03 | 2019-2025 | Hymovis |
| Sanofi-Aventis U.S. LLC | $72.93 | 2019-2023 | |
| Liberty Surgical INC. | $51.85 | 2021 | |
| Dynasplint Systems INC. | $35.00 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $30.93 | 2023 | Seglentis |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avanos Medical | $28.33 | 2019 | |
| Globus Medical, INC. | $27.47 | 2024 | Legacy Stelkast Hip, Distal Radius II, Legacy Stelkast Knee |
| Uoc USA INC | $26.15 | 2022 | |
| Bioventus LLC | $24.62 | 2023 | Durolane |
| Trice Medical, INC. | $21.05 | 2019 | |
| Endo USA, INC. | $16.87 | 2024 | Xiaflex |
| Davol INC. | $14.83 | 2023 | |
| Axogen | $11.90 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Birns listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.